CDC: Increase in Adverse Events Linked to Delta-8 THC Products
The delta-8 THC products have not been evaluated or approved by FDA for safe use in any context.
Complementary and Alternative Medicine
Warning Letters Sent to Companies Selling Supplements Claiming to Treat Diabetes
The FDA has not evaluated these products for safety or effectiveness.
Cholesterol Management Supplement Found to Contain Undeclared Rx Ingredient
Cholestene, a dietary supplement marketed for cholesterol management, has been found to contain a hidden drug ingredient, according to the Food and Drug Administration. Based on laboratory analysis, the product, which is sold on various websites and in some retail stores, has been found to contain lovastatin, an HMG-CoA reductase inhibitor (statin). Consuming a supplement…
Low FODMAP Diet and IBD: A Potential Option?
Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.
Tai Chi Helps Reduce Central Obesity in Adults 50 Years or Older
Reductions in waist circumference seen in tai chi and conventional exercise groups compared with control group
FDA Cracks Down on Companies Selling Unproven Infertility Supplements
The claims made on these websites establish these products as drugs under the Federal Food, Drug, and Cosmetic Act; however, none were evaluated by the FDA.
FDA: Dietary Supplements Containing Kratom Seized
The consumption of kratom can lead to serious medical outcomes.
Fish Oil Products: Do The Serving Sizes Add Up to Cholesterol Benefits?
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.
Black Cohosh Appears Safe, but May Not Benefit Women With PCOS-Related Infertility
Black cohosh is a natural phytoestrogen product occasionally used in the management of PCOS-related infertility.
FDA Cracks Down on Companies Selling Unapproved CBD Products
The products described in the warning letters are being marketed as topical pain therapies, though none have actually been evaluated by the FDA.
